MOLBIO Stock Chart & Stats
1145.40
-97.40(-7.84%)
―
--
Day’s Range― - ―
52-Week Range925.80 - 1,261.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
₹143.22B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding115,240,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MOLBIO FAQ
What was Molbio Diagnostics Limited’s price range in the past 12 months?
Molbio Diagnostics Limited lowest stock price was 925.80 and its highest was 1261.00 in the past 12 months.
What is Molbio Diagnostics Limited’s market cap?
Molbio Diagnostics Limited’s market cap is ₹143.22B.
When is Molbio Diagnostics Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Molbio Diagnostics Limited’s earnings last quarter?
Currently, no data Available
Is Molbio Diagnostics Limited overvalued?
According to Wall Street analysts Molbio Diagnostics Limited’s price is currently Undervalued.
Does Molbio Diagnostics Limited pay dividends?
Molbio Diagnostics Limited does not currently pay dividends.
What is Molbio Diagnostics Limited’s EPS estimate?
Molbio Diagnostics Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Molbio Diagnostics Limited have?
Molbio Diagnostics Limited has 115,240,000 shares outstanding.
What happened to Molbio Diagnostics Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Molbio Diagnostics Limited?
Currently, no hedge funds are holding shares in IN:MOLBIO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Molbio Diagnostics Limited
Molbio Diagnostics Limited, a point-of-care diagnostics company, provides healthcare technologies to diagnose infectious and non-communicable diseases. It manufactures and sells chip based diagnostic devices, chips and reagents, X-ray equipment's, and single/dual detectors. It also offers disposable POCT devices, which includes dengue, malaria, and COVID-19 tests; Tabletop analysers, a portable machine that are used to perform molecular or immunodiagnostic tests to detect infectious diseases, such as tuberculosis, human papillomavrus, STIs, and GI disorders. In addition, the company offers Truenat, a multi-disease real-time polymerase chain reaction platform that enables treatment decisions for various infectious and non-communicable diseases, such as tuberculosis, human immunodeficiency virus, malaria, viral hepatitis, COVID-19, dengue, chikungunya, influenza, H1N1, HPV/cervical cancer, cholera, leprosy, etc.; and Truenat assays. The company was incorporated in 2000 and is based in Verna, India.